Ditchcarbon
  • Customers
  1. Organizations
  2. Freenome Holdings, Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 5 months ago

Freenome Holdings, Inc.

Company website

Freenome Holdings, Inc., a pioneering force in the biotechnology sector, is headquartered in the United States. Founded in 2014, the company has rapidly established itself as a leader in the development of advanced multi-omics technology for early cancer detection. Freenome's innovative approach combines artificial intelligence with blood-based biomarker analysis, offering unique insights that enhance diagnostic accuracy. With a focus on colorectal cancer screening, Freenome's flagship product stands out for its ability to detect cancer at its earliest stages, significantly improving patient outcomes. The company has achieved notable milestones, including partnerships with leading healthcare institutions and recognition for its contributions to cancer diagnostics. As a key player in the oncology landscape, Freenome continues to drive advancements that redefine cancer detection and management.

DitchCarbon Score

How does Freenome Holdings, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Freenome Holdings, Inc.'s score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.

23%

Let us know if this data was useful to you

Freenome Holdings, Inc.'s reported carbon emissions

Freenome Holdings, Inc., headquartered in the US, currently does not have publicly available carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As such, Freenome's climate commitments and initiatives remain unclear. In the context of the industry, many companies are increasingly adopting science-based targets and sustainability initiatives to mitigate their environmental impact. However, without specific data or commitments from Freenome, it is challenging to assess their position in this regard. The company may need to establish clear climate strategies and reporting mechanisms to align with industry standards and expectations.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Freenome Holdings, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Freenome Holdings, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Freenome Holdings, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Veracyte

US
•
Pharmaceutical Preparation Manufacturing
Updated 11 days ago

C2I Genomics Inc.

US
•
Research and development services (73)
Updated 11 days ago

Nanostring Technologies

US
•
Pharmaceutical Preparation Manufacturing
Updated 11 days ago

Novogene Co., Ltd.

CN
•
Research and development services (73)
Updated 11 days ago

Adaptive Biotechnologies

US
•
Pharmaceutical Preparation Manufacturing
Updated 11 days ago

Personalis

US
•
Pharmaceutical Preparation Manufacturing
Updated 11 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250805.5
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy